Elicio Therapeutics, Inc. (ELTX) Financials

ELTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 22.7 million 24.1 million
Dec. 31, 2025 25.9 million 24.2 million
Sept. 30, 2025 28.3 million 24.5 million
June 30, 2025 29.5 million 27.7 million

ELTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -11.6 million 868000
Dec. 31, 2025 -6.8 million 772000
Sept. 30, 2025 -11.1 million 698000
June 30, 2025 -9.0 million 710000

ELTX Net Income

No data available :(

ELTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 14.9 million 3.8 million -
Dec. 31, 2025 18.6 million 4.1 million 5.1 million
Sept. 30, 2025 20.6 million 4.4 million 5.3 million
June 30, 2025 22.1 million 9.3 million 4.6 million

ELTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 18.2 million
Dec. 31, 2025 15.3 million
Sept. 30, 2025 16.7 million
June 30, 2025 16.1 million

ELTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 6.7 million 3.8 million -
Dec. 31, 2025 16000 5.1 million 3.8 million -
Sept. 30, 2025 - 5.0 million 3.0 million -
June 30, 2025 - 7.0 million 3.1 million -

ELTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 289000
Dec. 31, 2025 - 286000
Sept. 30, 2025 - 283000
June 30, 2025 - 281000

ELTX

Price: $2.76

52 week price:
2.76
14.93

Earnings Per Share: -2.36 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 253.1 million

Links: